Track topics on Twitter Track topics that are important to you
Israeli generics giant Teva Pharmaceutical (NYSE: TEVA) announced Thursday that it had appointed Eli Kalif as its new executive vice president and chief financial officer. Kalif, who was most recently a senior vice president, finance, at Flex (NASDAQ: FLEX), a US technological manufacturer, succeeds Mike McClellan, who held the role for the past two years.
Original Article: Teva Pharmaceutical Appoints Eli Kalif As New Chief Financial OfficerNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...